HomeBUSINESS
BUSINESS

3 Japan Drug Majors Launch Open Innovation Program for Drug Repositioning
(Oct.12.2017)

Astellas Pharma, Mitsubishi Tanabe Pharma, and Daiichi Sankyo said on October 11 that they will jointly launch an open innovation program for drug repositioning, providing a library of their development-terminated compounds to Japanese research institutions for the possible discovery of new therapeutics ...
(LOG IN FOR FULL STORY)

News Calendar